Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultra Small Dose Decitabine in Lower Risk MDS
NCT03045510Phase 2Unknown
- Sponsor
- Shandong University
- Start
- Dec 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of decitabine in myelodysplastic syndrome (MDS), sponsored by Shandong University. Status: unknown.
02
Drugs
decitabine
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT03045510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03045510.